Nestlé has launched a plant-based drink for toddlers named Little Steps Plantygrow, which can be added to smoothies and shakes.
The company emphasized that the plant-based 'Growing Up Drink,' marketed under its SMA Nutrition range, is not a breast milk substitute, but a nutritional product designed to be enjoyed by toddlers from 1 to 3 years old as part of a varied and balanced diet.
According to Nestlé, Little Steps is a good source of vitamins A, C, B2, and B12, iron, iodine and omega-3, and omega-6. The drink also contains calcium and vitamin D.
Vicky Woods, SMA Nutrition managing director, noted that consumers are increasingly choosing plant-based milk alternatives for themselves and as nutrient-packed options for their toddlers.
The new product is a ready-to-drink liquid that is packaged in resealable cartons for portability. Tesco and Asda carry a 200 ml pack. A 1-liter pack will be available at Asda.


Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
JPMorgan Lifts Gold Price Forecast to $6,300 by End-2026 on Strong Central Bank and Investor Demand
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Indian Rupee Strengthens Sharply After U.S.-India Trade Deal Announcement
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 



